- Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results From Randomized Phase 2b Core and Extension Studies2022 | 1. lékařská fakulta
- Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study A Randomized Clinical Trial2021 | 1. lékařská fakulta
- Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial2014 | 3. lékařská fakulta
- Měnící se paradigma v oblasti roztroušené sklerózy v imunopatogenezi a v terapii2022 | 1. lékařská fakulta
